Yours, Mine, or Ours? Navigating Intellectual Property Ownership in the Non-Profit Life Sciences

September 17, 2019 8:00 AM - 10:00 AM

MassBio, 300 Technology Square 8th Fl, Cambridge, MA 02139

Add to Calendar 9/17/2019 8:00:00 AM 9/17/2019 10:00:00 AM Yours, Mine, or Ours? Navigating Intellectual Property Ownership in the Non-Profit Life Sciences

Providing a new therapy or medical device to patients who will benefit generally requires commercial development. Development strategies are informed in part by patent laws governing ownership of intellectual property (IP), a complex landscape that must be navigated by non-profit organizations focused on advancing the development of new therapies for unmet medical needs. Join us for a discussion of the opportunities and challenges that non-profit organizations face in developing an IP strategy that will foster their mission effectively. Topics to be considered include:

  • Defining appropriate IP ownership expectations when awarding research grants.
  • Balancing research institution expectations of royalty returns with overall development investments and healthcare costs.
  • Managing conflicts of interest to ensure that patient benefit and safety remain the top priority.
 MassBio, 300 Technology Square 8th Fl, Cambridge, MA 02139
Senior Director of Innovation and Licensing Lead, Dana Farber
Emy Chen, PhD, is Senior Director of Licensing at the Robert and Renée Belfer Office for Dana-Farber Innovations (BODFI). In this role, she has oversight over the Innovations Licensing team as a whole. A primary focus for her will be to further refine and optimize the team's ability to provide excellent partnership and collaboration both with clinicians and research scientists at Dana-Farber and with external stakeholders in industry. Prior to joining BODFI, Emy was most recently a Director of Licensing at Partners HealthCare Innovation, where she spent 13 years supporting investigators and building relationships with biotech and pharma companies, primarily for innovators in the disciplines of Medicine, Neuroscience and Dermatology. Emy holds a PhD from Harvard University in Molecular and Cellular Biology, a BA from University of California, Berkeley in Molecular and Cell Biology, and is a registered patent agent with the United States Patent and Trademark Office (USPTO).